Innoviva Inc
INVA
$20.86-0.52%
End of day · as of Oct 16, 2026, 5:00 AM ET
Mkt cap
$1.66B
EV/Sales
3.33
P/E ratio
4.84
FY2025 Revenue
$411.33M
EPS (TTM)
$4.31
Gross Margin (FY2025)
74.80%
Profit Margin (FY2025)
65.92%
Beta
0.35
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Latest reported INVA revenue for 2025-12-31 was $411.3M. Net income was $271.2M. Revenue was up 14.7% from 2024-12-31 to 2025-12-31. INVA currently screens at market cap $1.66B and trailing P/E 4.8.
Use this INVA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INVA income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Innoviva Inc (INVA) is a biotechnology company in the Healthcare sector.
Latest cached Innoviva Inc (INVA) revenue for Dec 31, 2025 was $411.3M. Net income was $271.2M. Statements: https://lician.com/financials/inva
Innoviva Inc (INVA) trailing P/E is 4.84 on the latest cached fundamentals snapshot.
Innoviva Inc (INVA) market capitalization is $1.66B on the latest cached snapshot.
Innoviva Inc (INVA) cached previous close $20.97; day range $20.86 – $21.33; volume 622,034. Session quote: https://lician.com/quote/inva
Innoviva Inc (INVA) latest cached earnings event is "INVA earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings